{"protocolSection":{"identificationModule":{"nctId":"NCT04299841","orgStudyIdInfo":{"id":"2019-A01962-55"},"organization":{"fullName":"Ch Mont de Marsan","class":"OTHER"},"briefTitle":"Observational Study of the Evaluation of Post Traumatic Stress Post Stroke","officialTitle":"Stress Disorder Post-stroke: Observational Study of the Evaluation of Post Traumatic Stress Post Stroke (Stroke Post Traumatic Disorder)","acronym":"SPTD"},"statusModule":{"statusVerifiedDate":"2021-08","overallStatus":"WITHDRAWN","whyStopped":"lack of time","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2021-03","type":"ESTIMATED"},"primaryCompletionDateStruct":{"date":"2021-10-01","type":"ESTIMATED"},"completionDateStruct":{"date":"2021-12-01","type":"ESTIMATED"},"studyFirstSubmitDate":"2020-03-05","studyFirstSubmitQcDate":"2020-03-05","studyFirstPostDateStruct":{"date":"2020-03-09","type":"ACTUAL"},"lastUpdateSubmitDate":"2021-08-16","lastUpdatePostDateStruct":{"date":"2021-08-20","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR"},"leadSponsor":{"name":"Ch Mont de Marsan","class":"OTHER"}},"oversightModule":{"oversightHasDmc":false,"isFdaRegulatedDrug":false,"isFdaRegulatedDevice":false},"descriptionModule":{"briefSummary":"This prospective, observational, multicentre study evaluates the existence of Post-traumatic stress disorder following a stroke at 3 and 6 months after the management of the patient.\n\nQuestionnaires will be used to assess the presence of stroke post traumatic disorder.\n\nThe evaluation of stroke post traumatic disorder would allow to underline the importance of the awareness of the care teams in the the screening of these disorders and to evaluate if the Post-traumatic Stress Disorder Checklist Scale (PCL5) is an effective screening tool."},"conditionsModule":{"conditions":["Post Traumatic Stress Disorder"],"keywords":["PCL 5","Stroke"]},"designModule":{"studyType":"OBSERVATIONAL","patientRegistry":false,"designInfo":{"observationalModel":"OTHER","timePerspective":"PROSPECTIVE"},"enrollmentInfo":{"count":0,"type":"ACTUAL"}},"outcomesModule":{"primaryOutcomes":[{"measure":"Evaluate the number of patients managed for stroke and presenting Stroke Post Traumatic Disorder at 3 months after stroke","description":"Evaluate the number of patients managed for stroke and presenting Stroke Post Traumatic Disorder at 3 months after stroke. This evaluation will be made by completion of PCL-5 questionnaire (Post-traumatic stress disorder checklist version DSM-5 (DSM:Diagnostic and Statistical Manuel of Mental Disorders)). A PCL-5 positive score will be an indicator of post-traumatic stress disorder correlated with stroke.","timeFrame":"at time of inclusion (3 months after stroke)"}],"secondaryOutcomes":[{"measure":"Evaluate the number of patients managed for stroke and presenting Stroke Post Traumatic Disorder at 3 and at 6 months","description":"Evaluate the number of patients managed for stroke and presenting Stroke Post Traumatic Disorder at 3 and at 6 months. This evaluation will be made by completion of PCL-5 questionnaire (Post-traumatic stress disorder checklist version DSM-5). A PCL-5 positive score will be an indicator of post-traumatic stress disorder correlated with stroke. Two timepoint: 3 months and 6 months after stroke.","timeFrame":"at time of inclusion (3 months after stroke) and 6 months after stroke (study participation duration for patient: 3 months)"},{"measure":"Evaluate the number of patients presenting a depressive state at 3 months","description":"Evaluate the number of patients presenting a depressive state at 3 months after stroke. This evaluation was done by completion of HAD (Hospital Anxiety and Depression scale) questionnaire. A score between 8 and 10 will identify a doubtful depressive symptomatology and a score Superior to 11 will identify a certain depressive symptomatology.","timeFrame":"at time of inclusion (3 months after stroke)"},{"measure":"Evaluate the number of patients under antidepressant or anxiolytics treatment before the stroke","description":"The evaluation of the number of patients under antidepressant or anxiolytics treatment before the stroke will be made by the collection of previous treatments of the patient.","timeFrame":"at time of inclusion (3 months after stroke)"},{"measure":"Evaluate the PCL-5 questionnaire as a screening tool of the stroke post traumatic disorder","description":"Evaluate the PCL-5 questionnaire as a screening tool of the stroke post traumatic disorder by completion of PCL-5 questionnaire at two timepoint (3 and 6 months post-stroke). The presence of Post-traumatic Stress Disorder will be defined by threshold value of 38 as the total score on the PCL-5 questionnaire.","timeFrame":"at time of inclusion (3 months after stroke) and 6 months after stroke (study participation duration for patient: 3 months)"},{"measure":"Evaluate the traumatic history of the patient before the occurrence of the stroke","description":"Evaluate the number of patients presenting a depressive state at 3 months after stroke. This evaluation was done by completion of Trauma History Questionnaire (THQ).","timeFrame":"at time of inclusion (3 months after stroke)"},{"measure":"Evaluate the existence of a peritraumatic dissociation at the time of the occurrence of the stroke","description":"Evaluate the number of patients presenting a depressive state at 3 months after stroke. This evaluation was done by completion of PDEQ (Peritraumatic Dissociative Experience Questionnaire).","timeFrame":"at time of inclusion (3 months after stroke)"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Patient age \\> 18years old\n* Patient registered with a social security scheme\n* Patient who was given a written information and who gave his/her non-opposition\n* Patient who was hospitalized with a diagnosis of stroke in the neurology department and oriented to the post-stroke consultation (3 months after the hospital discharge) or un the follow-up care and readaptation department of hospital center of Dax or Mont de Marsan\n\nExclusion Criteria:\n\n* Patient with a serious disability sequelae (mRS\\>3),\n* Patient without enough level of proficiency in the French language,\n* Patient with neurocognitive and neurocognitive disorder diagnosed,\n* Patient with history of significant psychiatric disorders diagnosed,\n* Patient with seve aphasia","healthyVolunteers":true,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"],"studyPopulation":"Patient who was hospitalized with a diagnosis of stroke in the neurology department and oriented to the post-stroke consultation (3 months after the hospital discharge) or un the follow-up care and readaptation department of hospital center of Dax or Mont de Marsan","samplingMethod":"NON_PROBABILITY_SAMPLE"},"contactsLocationsModule":{"overallOfficials":[{"name":"Harold PERDIGNON","affiliation":"CH de Dax","role":"PRINCIPAL_INVESTIGATOR"},{"name":"Francine CLEMENTI, MD","affiliation":"CH de Dax","role":"STUDY_DIRECTOR"}],"locations":[{"facility":"centre hospitalier Dax","city":"Dax","zip":"40100","country":"France","geoPoint":{"lat":43.71032,"lon":-1.05366}}]}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000040921","term":"Stress Disorders, Traumatic"},{"id":"D000013313","term":"Stress Disorders, Post-Traumatic"}],"ancestors":[{"id":"D000068099","term":"Trauma and Stressor Related Disorders"},{"id":"D000001523","term":"Mental Disorders"}],"browseLeaves":[{"id":"M21996","name":"Stroke","relevance":"LOW"},{"id":"M24606","name":"Stress Disorders, Traumatic","asFound":"Stress Disorder","relevance":"HIGH"},{"id":"M15793","name":"Stress Disorders, Post-Traumatic","asFound":"Post Traumatic Stress Disorder","relevance":"HIGH"},{"id":"M17375","name":"Wounds and Injuries","relevance":"LOW"},{"id":"M222","name":"Trauma and Stressor Related Disorders","relevance":"LOW"},{"id":"M4505","name":"Mental Disorders","relevance":"LOW"},{"id":"M14163","name":"Psychotic Disorders","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BXM","name":"Behaviors and Mental Disorders"},{"abbrev":"BC26","name":"Wounds and Injuries"}]}},"hasResults":false}